Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults

Journal of Antibiotics

Volumn 67, Issue 8, 2014, Pages 555-557

  Peretz, Avi ^a,b   Paritsky, Maya ^a,b   Nasser, Omar ^a,b   Brodsky, Diana ^a,b   Glyatman, Tatyana ^a,b   Segal, Sofia ^a,b   On, Avi ^a,b  

^a Poriya Hospital   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG TREATMENT FAILURE; EPSILOMETER TEST; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISRAEL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; DRUG EFFECTS; EPIDEMIOLOGY; HELICOBACTER INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISRAEL; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TETRACYCLINE; YOUNG ADULT;

EID: 84906691872     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2014.38     Document Type: Article

References (17)

1. Kenneth, E. L. McColl. Clinical practice: Helicobacter pylori infection. New Engl. J. Med. 362, 1597-1604 (2010).
2. Blaser, M. J. & Atherton, J. C. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113, 321-333 (2004).
3. Magalhaes Queiroz, D. M. & Luzza, F. Epidemiology of Helicobacter pylori infection. Helicobacter 11(suppl 1), 11-15 (2006).
4. Delport, W. & van der Merwe, S. W. The transmission of Helicobacter pylori: the effects of analysis method and study population on inference. Best Pract. Res. Clin. Gastroenterol. 21, 215-236 (2007).
5. Gisbert, J. P. & Pajares, J. M. Review article: Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharm. Ther. 16, 1047-1057 (2002).
6. DeKaster, E. et al. Helicobacter pylori resistance to macrolides increases, to imidazole remains stable. Gastroenterol. 112, A99 (1997).
7. Crone, J. et al. Helicobacter pylori in children and adolescents: Increase of primary clarithromycin resistance, 1997-2000. J. Pediatr. Gastroenterol. Nutr. 36, 368-371 (2003).
8. Megraud, F. H. pylori antibiotic resistance: prevalence, importance and advance in testing. Gut 53, 1374-1384 (2004).
9. ClSI. Method for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline- second edition. M45-A2:30 No.18 (Clinical and Laboratory Standards Institute, Pennsylvania, USA, 2012).
10. BSAC. Methods for antimicrobial susceptibility testing. version 7 (2008).
11. Holmes, K. P., Fang, J. C. & Jackson, B. R. Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern. BMC. Health Serv. Res. 10, 334-340 (2010).
12. McNulty, C. A. M., Lehours, P. & Mègraud, F. Diagnosis of Helicobacter pylori Infection. Helicobacter 16(suppl. 1), 10-18 (2011).
13. O'Connor, A. et al. Treatment of Helicobacter pylori Infection. Helicobacter 15, 46-52 (2010).
14. Malfertheiner, P. et al. Management of Helicobacter pylori infection - the Maastricht IV/ Florence consensus report. Gut. 61, 646-664 (2012).
15. Avidan, B. et al. Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 137, 272-274 (1999).
16. De Francesco, V. et al. Worldwide H. pylori antibiotic resistance: a systematic review. J. Gastrointestin. Liver. Dis. 19, 409-414 (2010).
17. Gisbert, J. P. et al. H. pylori Study Group of the Asociación Española de Gastroenterología. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am. J. Gastroenterol. 103, 71-76 (2008).